FATE
Price
$0.69
Change
-$0.08 (-10.39%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
78.95M
27 days until earnings call
KTTA
Price
$1.27
Change
+$0.08 (+6.72%)
Updated
Apr 3, 04:51 PM (EDT)
Capitalization
3.22M
Ad is loading...

FATE vs KTTA

Header iconFATE vs KTTA Comparison
Open Charts FATE vs KTTABanner chart's image
Fate Therapeutics
Price$0.69
Change-$0.08 (-10.39%)
Volume$48.64K
Capitalization78.95M
Pasithea Therapeutics
Price$1.27
Change+$0.08 (+6.72%)
Volume$1K
Capitalization3.22M
FATE vs KTTA Comparison Chart
Loading...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KTTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FATE vs. KTTA commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FATE is a Hold and KTTA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (FATE: $0.77 vs. KTTA: $1.19)
Brand notoriety: FATE and KTTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FATE: 160% vs. KTTA: 2%
Market capitalization -- FATE: $78.95M vs. KTTA: $3.44M
FATE [@Biotechnology] is valued at $78.95M. KTTA’s [@Biotechnology] market capitalization is $3.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FATE’s FA Score shows that 1 FA rating(s) are green whileKTTA’s FA Score has 1 green FA rating(s).

  • FATE’s FA Score: 1 green, 4 red.
  • KTTA’s FA Score: 1 green, 4 red.
According to our system of comparison, KTTA is a better buy in the long-term than FATE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FATE’s TA Score shows that 4 TA indicator(s) are bullish while KTTA’s TA Score has 5 bullish TA indicator(s).

  • FATE’s TA Score: 4 bullish, 4 bearish.
  • KTTA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, KTTA is a better buy in the short-term than FATE.

Price Growth

FATE (@Biotechnology) experienced а -9.85% price change this week, while KTTA (@Biotechnology) price change was -13.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

FATE is expected to report earnings on Apr 30, 2025.

KTTA is expected to report earnings on Feb 28, 2024.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FATE($78.9M) has a higher market cap than KTTA($3.22M). FATE YTD gains are higher at: -53.333 vs. KTTA (-62.222). KTTA has higher annual earnings (EBITDA): -15.49M vs. FATE (-176.58M). FATE has more cash in the bank: 279M vs. KTTA (9.36M). KTTA has less debt than FATE: KTTA (0) vs FATE (85.3M). FATE has higher revenues than KTTA: FATE (13.6M) vs KTTA (0).
FATEKTTAFATE / KTTA
Capitalization78.9M3.22M2,451%
EBITDA-176.58M-15.49M1,140%
Gain YTD-53.333-62.22286%
P/E RatioN/AN/A-
Revenue13.6M0-
Total Cash279M9.36M2,980%
Total Debt85.3M0-
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FATEKTTA
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 23 days ago
85%
Bullish Trend 11 days ago
69%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KTTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NTRA143.202.55
+1.81%
Natera
MCW8.060.14
+1.77%
Mister Car Wash Inc
AOUT12.210.12
+0.99%
American Outdoor Brands
KWE0.26N/A
-0.83%
Kwesst Micro Systems Inc
VEL18.45-0.16
-0.86%
Velocity Financial

KTTA and

Correlation & Price change

A.I.dvisor tells us that KTTA and FATE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KTTA and FATE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KTTA
1D Price
Change %
KTTA100%
-4.03%
FATE - KTTA
32%
Poorly correlated
+1.70%
ACET - KTTA
25%
Poorly correlated
-1.50%
SPRB - KTTA
24%
Poorly correlated
+9.21%
TRAW - KTTA
24%
Poorly correlated
+8.41%
HEPA - KTTA
24%
Poorly correlated
-1.44%
More